Table 1.
Demographics and clinicopathologic characteristics of EOC patients
| Variable | Number (%) |
|---|---|
| Age, y (mean ± SD) | 51.6±8.94 |
| <50 | 24 (38.7%) |
| ≥50 | 38 (61.29) |
| Stage | |
| I | 13 (21.0%) |
| II | 9 (14.5%) |
| III | 36 (58.1%) |
| IV | 4 (6.4%) |
| Histological Type | |
| Serous | 49 (79.0%) |
| Endometrioid | 6 (9.7%) |
| Mucinous | 7 (11.3%) |
| Histological Grade | |
| G1 (Well differentiated) | 9 (14.5%) |
| G2 (Moderately differentiated) | 17 (27.4%) |
| G3 (Poorly differentiated) | 36 (58.1%) |
| Residual tumor diameter (cm) | |
| ≤1 | 45 (72.6%) |
| >1 | 17 (27.4%) |
| Ascites (mL) | |
| <100 | 19 (30.6%) |
| ≥100 | 43 (69.4%) |
| CA125 (U/mL) | |
| <600 | 35 (56.5%) |
| ≥600 | 27 (43.5%) |
Abbreviation: EOC, epithelial ovarian cancer.